Meeting
2022 ASCO Annual Meeting
The HERPET study: Imaging HER2 expression in breast cancer with the novel PET tracer [18F]GE-226, a first-in-patient study.
Authors
Laura M. Kenny
Imperial College London, London, United Kingdom
Laura M. Kenny , Fiona J Gilbert , Gosala Gopalakrishnan , Preetha Aravind , Tara Barwick , Neva Patel , Duncan ROBERT Hiscock , Istvan Boros , Steven Kealey , Franklin I Aigbirhio , Jingky Lozano-kuehne , Susan Jane Cleator , Ben Fleming , Pippa Riddle , Rizvana Ahmad , Sue Chua , Stephen R.D. Johnston , Janine Mansi , Gary J. Cook , Eric O. Aboagye
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Clinical Trial Registration Number
NCT03827317
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3069)
DOI
10.1200/JCO.2022.40.16_suppl.3069
Abstract #
3069
Poster Bd #
61
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Imaging HER2-positive metastatic esophagogastric cancer with 89Zr-trastuzumab PET and 18F-FDG PET.
First Author: Melissa Amy Lumish
Poster
2018 ASCO Annual Meeting
Frequency of overexpression of HER3 and prognostic consequences in European patients with early gastric cancer.
First Author: Nieves Martinez Lago
Poster
2013 ASCO Annual Meeting
Comparison of HER2 expression in paired biopsies and surgical specimen of gastric and esophageal adenocarcinoma: Impact of neoadjuvant chemotherapy.
First Author: Sarah Watson
Poster
2012 ASCO Annual Meeting
64Cu-DOTA-trastuzumab-PET imaging in patients with HER2-positive breast cancer.
First Author: Kenji Tamura